Core Viewpoint - The company, Shuangqiang Technology, plans to develop its future blockbuster products through collaboration with benchmark retail clients and by expanding into new categories and scenarios [1] Group 1: Product Development Strategy - The company aims to create blockbuster products by collaborating with benchmark retail clients such as Pang Donglai and Sam's Club to meet their customized needs [1] - The company plans to expand into new product categories and scenarios, including cookware and cutlery, by integrating market resources and leveraging a mature supply chain [1] - The company has already established a presence in the e-commerce cookware and cutlery sectors and plans to further integrate its cookware supply chain by 2026 to enhance production capacity [1]

Group 1 - The company, Shuangqiang Technology, announced that it will hold an investor meeting on February 5, 2026, from 15:00 to 14:30, with participation from key executives including the Secretary of the Board and CFO Zhu Weiqing, Vice President and General Manager of the New Materials Division Xu Hongchang, and representatives Zhang Chi and Lei Li [1] Group 2 - The meeting aims to address questions from investors, indicating the company's commitment to transparency and engagement with stakeholders [1]

证券代码：001211 证券简称：双枪科技 双枪科技股份有限公司 2026 年 2 月 5 日投资者关系活动记录表 编号：2026-001 | 投资者关系 | 特定对象调研 分析师会议 媒体采访 | | --- | --- | | 活动类别 | 业绩说明会 新闻发布会 路演活动 | | | 现场参观 其他 | | 活动参与人员 | 兴业证券赵宇、浙商证券史凡可、浙商证券曹馨茗、国投 | | | 证券罗乾生、华安证券徐偲、华安证券余倩莹、国泰海通 | | | 毛宇翔、申银万国魏雨辰、天风证券张彤、华西证券杜磊、 | | | 财通证券戚志圣、华福证券汪浚哲、国元证券朱宇昊、东 | | | 方财富叶柏辉、信达证券李晨、华夏基金郑楷樾、华创证 | | | 券周星宇等 | | 时间 | 年 月 日（星期四）15:00-14:30 2026 2 5 | | 地点 | 线上调研会议 | | 上市公司接待人员 | 董事会秘书兼财务总监：朱卫清先生 | | | 董事、副总经理、新材料事业部总经理：徐洪昌先生 | | | 证券事务代表：张驰女士、雷丽女士 | | 交流内容及具体问 | 一、公司介绍 | | | 公 ...

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

Core Viewpoint - The company announced that its director, Zhou Zhaocheng, plans to reduce his shareholding by selling up to 230,400 shares, which represents 0.32% of the total share capital, within three months after a 15 trading day period following the announcement [1] Summary by Categories Shareholding Information - Zhou Zhaocheng holds 921,400 shares, accounting for 1.30% of the total share capital [1] - The shares to be sold are from those issued prior to the initial public offering [1]

Group 1 - The core point of the announcement is that director Zhou Zhaocheng of Shuangqiang Technology plans to reduce his shareholding by up to 230,350 shares, which is 0.32% of the company's total share capital, within three months after a 15 trading day period from the announcement date [2][4][6] - Zhou Zhaocheng currently holds 921,402 shares, representing 1.30% of the company's total share capital [2][3] - The reduction is intended to meet personal funding needs and will be executed through centralized bidding transactions [4][6] Group 2 - The company has received a guarantee request for its subsidiary, Anji Shuangqiang Bamboo Industry Co., Ltd., with a maximum guarantee amount of 120 million yuan from China CITIC Bank [13][15] - The total guarantee amount for the company's subsidiaries is estimated at 818.5 million yuan, approved by the board and shareholders [12][18] - After this guarantee, the actual external guarantee balance provided by the wholly-owned subsidiary to the company will be 90 million yuan, accounting for 10.33% of the company's latest audited net assets [18]

Summary of Key Points Core Viewpoint - The article highlights the recent stock buyback and reduction activities of various A-share listed companies, indicating potential shifts in investor sentiment and company strategies in the market [1]. Group 1: Stock Buyback Activities - Changhong Huayi: Some directors and senior management plan to increase their shareholding in the company [2]. - Pianzihuang: The controlling shareholder has obtained a special loan commitment for a buyback of up to 450 million yuan [2]. - Gaweida: The board proposes a share repurchase plan amounting to 30 million to 35 million yuan [2]. - Changan Automobile: Plans to repurchase shares worth between 1 billion to 2 billion yuan [2]. Group 2: Stock Reduction Activities - Shengke Communication: Recently, the National Integrated Circuit Industry Investment Fund reduced its stake by 0.6% of the total share capital [2]. - Furi Technology: Shareholders plan to reduce their holdings by up to 2% of the total share capital [2]. - Pulit: Shareholders Zhou Wu and executive Li Hong plan to collectively reduce their holdings by up to 0.57% [2]. - Nankuang Group: The executive vice president plans to reduce his stake by up to 1% [2]. - Qinda Environmental Protection: Shareholder Binglun Environment plans to reduce holdings by up to 3% [2]. - Fuchuang Precision: Shareholder Guotou Chuangyi plans to reduce holdings by up to 3% [2]. - Shuangqiang Technology: Director Zhou Zhaocheng plans to reduce holdings by up to 0.32% [2]. - Debi Group: The controlling shareholder plans to reduce holdings by up to 1.92% [2]. - Jinpu Garden: Shareholders plan to reduce their stakes by 1% each [2]. - Kangsi Te: Shareholders plan to reduce their holdings [2]. - Guangda Jiabao: Shareholders plan to reduce their holdings by up to 1% [2]. - Baogang Jin: Director Yuan Xiaofeng plans to reduce holdings by up to 0.0923% [2]. - ST Lutong: Shareholders plan to reduce their holdings by up to 3.33% [2]. - Zhang Xiaoqin: Shareholder plans to reduce holdings by up to 0.31% [2]. - Yuxing Co.: Shareholder Huang Shiliu plans to reduce holdings by up to 0.22% [2]. - Guai Bao Pet: Shareholders plan to reduce their holdings by up to 1.90% [2]. - Kaipu Biological: Shareholder plans to reduce holdings by up to 3% [2]. - Jiangshan Oupai: Shareholder Wang Zhong plans to reduce holdings by up to 3% [2]. - Fuguang Co.: Shareholder plans to reduce holdings by up to 3% [2].

证券日报网讯 2月4日，双枪科技发布公告称，持有公司股份921，402股（占公司总股本比例为1.30%） 的董事周兆成先生计划在本公告披露之日起15个交易日后的3个月内通过集中竞价交易方式减持公司股 份不超过230，350股，不超过公司总股本的0.32%（公司总股本的有效计算基数为70，954，300股，即 目前总股本72，000，000股剔除公司回购专用证券账户中持有的1，045，700股）。 （编辑 任世碧） ...

证券日报网讯 2月4日，双枪科技发布公告称，截至本公告披露日，公司不存在为合并报表外的单位提 供担保，无逾期债务对应的担保余额、无涉及诉讼的担保金额及因被判决败诉而应承担的担保金额。 （文章来源：证券日报） ...

证券代码：001211 证券简称：双枪科技 公告编号：2026-004 二、担保进展情况 近日，公司与中信银行股份有限公司杭州临平支行签署了《最高额保证合同》，为 安吉双枪竹业有限公司的银行授信提供连带责任保证。具体情况如下： | 序 | 担保方 | 被担保方 | 融资机构／ | 担保金额 | 担保方式 | 担保期限 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 债权人 | （万元） | | | | | | 双枪科技股份 | 安吉双枪竹业有 | 中信银行股 份有限公司 | | | 不超过 10 | | | 1 | 有限公司 | 限公司 | 杭州临平支 | 12,000 | 连带责任保证 | | 年 | | | | | 行 | | | | | 本次担保在公司已审批的担保额度范围内。 三、被担保人基本情况 双枪科技股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保情况概述 双枪科技股份有限公司（以下简称"本公司"或"公司"）于 20 ...